Abstract
AbstractChronic Obstructive Pulmonary Disease (COPD) is a life-threatening lung disease, affecting millions of people worldwide. Implementation of Machine Learning (ML) techniques is crucial for the effective management of COPD in home-care environments. However, shortcomings of cloud-based ML tools in terms of data safety and energy efficiency limit their integration with low-power medical devices. To address this, energy efficient neuromorphic platforms can be used for the hardware-based implementation of ML methods. Therefore, a memristive neuromorphic platform is presented in this paper for the on-chip recognition of saliva samples of COPD patients and healthy controls. Results of its performance evaluations showed that the digital neuromorphic chip is capable of recognizing unseen COPD samples with accuracy and sensitivity values of 89% and 86%, respectively. Integration of this technology into personalized healthcare devices will enable the better management of chronic diseases such as COPD.
Funder
Bundesministerium für Bildung und Forschung
Deutsche Forschungsgemeinschaft
Projekt DEAL
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Barnes, P. J. Mechanisms in COPD: Differences from asthma. Chest 117(2), 10S-14S (2000).
2. Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3(11), e442 (2006).
3. Csikesz, N. G. & Gartman, E. J. New developments in the assessment of COPD: Early diagnosis is key. Int. J. Chron. Obstruct. Pulmonary Dis. 9, 277 (2014).
4. Price, D. et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Primary Care Respir J. 18(3), 216–223 (2009).
5. Dong, T., Santos, S., Yang, Z., Yang, S. & Kirkhus, N. E. Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD. Analyst 145(5), 1583–1604 (2020).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献